Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,029 | -2,943 | -10,782 | -6,834 | -5,518 |
| Depreciation Amortization | 188 | 96 | 425 | 326 | 220 |
| Other Working Capital | 168 | -86 | 501 | 445 | 489 |
| Other Operating Activity | 70 | 339 | 702 | -413 | 887 |
| Operating Cash Flow | $-4,602 | $-2,595 | $-9,155 | $-6,476 | $-3,923 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -15 | -148 | -135 | -93 |
| Other Investing Activity | 0 | 0 | 2,000 | 2,000 | 122 |
| Investing Cash Flow | $-15 | $-15 | $1,852 | $1,865 | $29 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | 4,000 | N/A | N/A | N/A |
| Debt Repayment | -1 | -1 | -2 | -2 | -1 |
| Common Stock Issued | N/A | N/A | 4,975 | 4,975 | 4,975 |
| Other Financing Activity | -174 | 0 | 71 | 71 | 71 |
| Financing Cash Flow | $3,825 | $3,999 | $5,043 | $5,044 | $5,045 |
| Beginning Cash Position | 2,418 | 2,418 | 4,678 | 4,678 | 4,678 |
| End Cash Position | 1,626 | 3,808 | 2,418 | 5,111 | 5,828 |
| Net Cash Flow | $-792 | $1,390 | $-2,259 | $433 | $1,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,602 | -2,595 | -9,155 | -6,476 | -3,923 |
| Capital Expenditure | -15 | -15 | -148 | -135 | -93 |
| Free Cash Flow | -4,618 | -2,610 | -9,302 | -6,611 | -4,016 |